Renal Cancer - Results from #1040

The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm. March 14, 2023

Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer. March 14, 2023

B7-H3 expression is associated with high PD-L1 expression in clear cell renal cell carcinoma and predicts poor prognosis. March 13, 2023

Transcriptome mapping of renal clear cell carcinoma revealed by machine learning algorithm based on enhanced CT images. March 13, 2023

Superiority of magnetic resonance imaging in small renal mass diagnosis where image reports mismatches between computed tomography and magnetic resonance imaging. March 10, 2023

Diagnostic Imaging in the Evaluation of Asymptomatic Microhematuria: Systematic Review and Meta-Analysis. March 10, 2023

Multidisciplinary Team (MDT) Discussion Improves Overall Survival Outcomes for Metastatic Renal Cell Carcinoma Patients. March 9, 2023

The effect of perioperative blood transfusion on survival after renal cell carcinoma nephrectomy: A systematic review and meta-analysis. March 9, 2023

The IRON Study: Investigation of Robot-assisted Versus Open Nephron-sparing Surgery. March 8, 2023

Real-world Treatment Patterns and Clinical Outcomes for Metastatic Renal Cell Carcinoma in the Current Treatment Era. March 8, 2023

The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training. March 8, 2023

Characterization and Management of Adverse Reactions From the CLEAR Study in Advanced Renal Cell Carcinoma Treated With Lenvatinib Plus Pembrolizumab. March 7, 2023

Factors associated with clinical trial participation for patients with renal cell carcinoma. March 7, 2023

Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. March 6, 2023

Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy. March 6, 2023

Comprehensive Management of Renal Masses in Solitary Kidneys. March 6, 2023

Trends of kidney cancer burden from 1990 to 2019 in European Union 15 + countries and World Health Organization regions. March 6, 2023

Exelixis Provides Update on Phase 3 CONTACT-03 Trial Evaluating Cabozantinib in Combination with Atezolizumab in Patients with Previously Treated Advanced Kidney Cancer March 3, 2023

The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma. March 3, 2023

Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study. March 3, 2023

Page 53 of 456